No Strict Contraindication for Diclofenac in Children Under 12 Years
There is no research article or guideline stating that diclofenac is strictly contraindicated in children under 12 years of age. The available evidence shows diclofenac is used in pediatric populations, though with important safety considerations and limited FDA approval for specific indications.
FDA Labeling and Regulatory Status
The FDA drug label for diclofenac does not list age under 12 years as a contraindication 1. The actual FDA contraindications for diclofenac are:
- Known hypersensitivity to diclofenac
- History of asthma, urticaria, or allergic reactions to aspirin or other NSAIDs
- In the setting of coronary artery bypass graft (CABG) surgery
The FDA label states: "Pediatric Use: Safety and effectiveness in pediatric patients have not been established" 1. This means diclofenac lacks FDA approval for pediatric use, but this is distinctly different from being contraindicated.
Clinical Practice Evidence
Multiple guidelines and research studies demonstrate diclofenac is actively used in children:
Guideline Support:
- The 2024 ESPA (European Society for Paediatric Anaesthesiology) pain management guideline includes specific dosing recommendations for diclofenac in children: 0.5-1 mg/kg every 8 hours rectally, 1 mg/kg every 8 hours orally 2
- The 2025 Pan-American League guideline for juvenile idiopathic arthritis acknowledges diclofenac can be used "at the discretion of the treating physician based on clinical experience," though it notes lack of FDA/EMA approval for pediatric use 3
- The 2019 breastfeeding guideline states diclofenac "has been used extensively during lactation and is considered safe" 4
Research Evidence:
- A 2011 pharmacokinetic meta-analysis specifically studied diclofenac dosing in children aged 1-12 years, recommending 0.3 mg/kg IV, 0.5 mg/kg rectal, and 1 mg/kg oral 5
- A 2023 Cochrane review analyzed 32 RCTs involving 2,250 children receiving diclofenac for postoperative pain 6
- A 2025 Malaysian study analyzed 1,958 pediatric prescriptions, finding diclofenac was the second most commonly prescribed NSAID after ibuprofen (12.75% of prescriptions) 7
- A 2007 UK survey found 86% of pediatric anesthesiologists use NSAIDs in infants, with diclofenac being the most common choice (78%) 8
Important Distinction: Codeine vs. Diclofenac
You may be confusing diclofenac with codeine, which IS strictly contraindicated in children under 12 years. The 2019 AAO-HNS tonsillectomy guideline provides a "strong recommendation against" codeine use in children <12 years, based on FDA boxed warnings from 2013 and contraindication added in April 2017 9. This followed 21 deaths in children <12 years from respiratory depression due to ultra-rapid metabolizer status.
Safety Considerations for Diclofenac in Children
While not contraindicated, diclofenac use in children requires careful consideration:
Bleeding Risk:
- When compared to opioids, diclofenac probably increases bleeding events (RR 3.06,95% CI 1.31-7.13) 6
- This is particularly relevant for tonsillectomy, though the 2019 guideline notes NSAIDs as a class (including ibuprofen) did not significantly increase bleeding risk in 1,100 children across 15 studies 9
Gastrointestinal and Cardiovascular Risks:
- The 2007 American Heart Association statement notes diclofenac carries cardiovascular thrombotic event risks, though this was primarily studied in adults 10
- Standard NSAID precautions apply: GI bleeding, renal toxicity, hepatotoxicity 1
Off-Label Use:
- Most diclofenac use in children is off-label, meaning prescribers must weigh benefits against risks based on pharmacological knowledge rather than FDA-approved efficacy data 8, 6
Clinical Bottom Line
Diclofenac is not contraindicated in children under 12 years, but it is not FDA-approved for this age group. It is widely used off-label in pediatric anesthesia and pain management with established dosing regimens. The confusion may stem from codeine's strict contraindication in this age group. When using diclofenac in children, consider bleeding risk (especially for tonsillectomy), use age-appropriate dosing, and monitor for standard NSAID adverse effects.